Glancy prongay & murray llp reminds investors of looming deadline in the class action lawsuit against athira pharma, inc. (atha)

Los angeles, aug. 5, 2021 /prnewswire/ --  glancy prongay & murray llp ("gpm") reminds investors of the upcoming  august 24, 2021 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired athira pharma, inc. ("athira" or the "company") (nasdaq: atha): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "registration statement") issued in connection with the company's september 2020 initial public offering ("ipo" or the "offering"); and/or (b) securities between september 18, 2020 and june 17, 2021 , inclusive (the "class period"). if you suffered a loss on your athira investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/athira-pharma-inc/.
ATHA Ratings Summary
ATHA Quant Ranking